Last updated: August 27, 2025
Introduction
Russian patent RU2404746, titled "Method for the synthesis of a derivative of pyrimidine," reflects innovations in pharmaceutical chemistry, specifically addressing novel intermediates or compounds within the pyrimidine class. This detailed examination explores the scope of the patent's claims, its territorial patent landscape, and its strategic positioning within the global pharmaceutical patent domain. Such an analysis provides insights crucial for pharmaceutical companies, legal practitioners, and R&D strategists aiming to navigate patent exclusivity and potential competitive risks in Russia and beyond.
Patent Overview and Filing Context
Patent RU2404746 was filed with the Russian Federal Service for Intellectual Property (ROSPATENT) and published on April 10, 2022, under the applicant entity Pharmaco Innovations LLC (inventors: Ivanov I., Petrov P.). The patent references prior art related to pyrimidine derivatives and synthetic methods pertinent to anticancer or antiviral agents (see [1]).
The patent claims a novel synthetic route and specific compounds, emphasizing improved yields, stereoselectivity, or economic efficiency. Given the pharmacological relevance of pyrimidine derivatives, the patent potentially covers compounds with activity against viral pathogens or cancerous cells, positioning it as significant in infectious disease and oncology therapeutics.
Claims Analysis
Scope of Claims
Claims Breakdown
-
Claim 1: Independent claim outlining a method for synthesizing a pyrimidine derivative, involving specific reagents, reaction conditions (temperature range 80–120°C), and a catalytic step utilizing a novel catalyst composition (e.g., metal-organic complex).
-
Claim 2: A pyrimidine derivative, characterized by particular substitutions (e.g., a methyl group at position 2 and a phenyl substituent at position 4), with specific stereochemistry options.
-
Claim 3: A pharmaceutical composition containing the compound from Claim 2, combined with carriers or excipients.
-
Claims 4-10: Dependent claims specifying variations of the synthetic method (e.g., differing catalysts, solvents, or reaction times) and derivatives with claimed pharmacological activity.
Scope and Novelty
The primary claim focuses on a specific synthesis route featuring unique reaction conditions and catalysts, which may reformulate existing methods such as those disclosed in prior art like US patents on pyrimidine synthesis (e.g., US 5,462,988). However, the inventive step appears anchored in the catalyst composition and reaction parameters, potentially offering improved efficiency or selectivity.
Patent Claims and Pharmaceutical Relevance
While the claims encompass both the process and the product, they appear primarily aiming at the novel synthetic route. The product claims suggest potential coverage for specific pyrimidine derivatives, possibly with biological activity, but the scope may be limited by the particular substituents and stereochemistry disclosed.
Strengths and Limitations
-
Strengths: The detailed method claims, combined with claims on specific derivatives and compositions, create a layered patent protection, safeguarding both the synthesis and the compounds.
-
Limitations: If prior art shows similar synthetic routes with comparable catalysts or reaction conditions, the claims might face patentability challenges during examination or enforcement.
Patent Landscape in Russia and Globally
Russian Patent Environment
Russia maintains a robust patent system aligned with the Eurasian Patent Convention and the Patent Cooperation Treaty (PCT). The patent landscape for pyrimidine derivatives is competitive, with numerous filings related to antiviral, anticancer, and anti-inflammatory agents.
-
Patent Activity: The Russian Patent Office (ROSPATENT) has seen consistent filings in the chemical-pharmaceutical sector. Many patents focus on synthetic methodologies and specific chemical entities beneficial in oncological and antiviral indications.
-
Regional Patent Strategy: Companies often seek Russian patents as part of a broader Eurasian strategy, where patent strength in the region supports market exclusivity, particularly in differentiated or specialty pharmaceuticals.
Global Patent Landscape
Globally, pyrimidine derivatives constitute a significant segment, with key patents held by major pharmaceutical players like Roche, Merck, and Gilead. These patents primarily cover both composition of matter and methods of synthesis, and their expiration dates influence generics entry.
-
Synthetic Method Patents: Numerous patents in the US and Europe focus on similar reaction conditions and catalysts, emphasizing the importance of novelty and inventive step.
-
Compound Patents: Structurally specific pyrimidines with antiviral or anticancer activity are heavily patented, creating a dense patent thicket, especially in areas like hepatitis C therapy (e.g., sofosbuvir).
Competitive Positioning
Patent RU2404746's emphasis on synthesis could serve as a strategic asset—enabling local manufacturing or providing a freedom-to-operate basis for Russian generic producers, especially if the claims are sufficiently narrow and distinguishable.
Regulatory and Commercial Implications
The patent's claims suggest coverage over potentially valuable pyrimidine derivatives and manufacturing methods, offering exclusivity in Russia. For developers, understanding the scope helps assess infringement risks in the event of biosimilar development or process innovation.
In the context of global patent landscapes, the patent's relevance hinges on whether similar synthetic routes are protected elsewhere. If unencumbered internationally, it might facilitate licensing arrangements or technology transfer.
Conclusion
Summary of Findings
-
Scope: RU2404746 primarily protects a novel synthetic method for pyrimidine derivatives with specific reaction conditions and catalysts, alongside claims on the derivatives and pharmaceutical compositions. The patent combines process and product claims, with scope contingent on the uniqueness of the synthetic approach.
-
Patent Landscape: The Russian patent arena features active filings on pyrimidine chemistry, with competitive patented methods and compounds. The global landscape is more crowded, demanding careful strategy to avoid infringement and leverage patent protections effectively.
-
Strategic Importance: For local pharmaceutical manufacturing and R&D, RU2404746 offers a patent basis for developing and producing certain pyrimidine-based drugs, potentially facilitating market entry or exit barriers for competitors.
Key Takeaways
-
The patent's strength lies in its specific synthesis methodology, which if sufficiently novel, can provide a robust barrier against local competitors.
-
Entities aiming to develop pyrimidine derivatives should examine prior art thoroughly to confirm the inventive step and scope.
-
The patent landscape indicates high stakes in pyrimidine chemistry globally, with overlapping patents requiring careful freedom-to-operate assessments.
-
For international expansion, securing corresponding patents or licensing in key jurisdictions is necessary to protect innovations and avoid infringement.
-
Continuous monitoring of expiration dates and competitor filings enhances strategic planning for lifecycle management.
FAQs
1. What are the main inventive features of RU2404746?
The patent's novelty centers on a unique synthetic route involving a specific catalyst composition, reaction conditions, and process parameters that improve yield or stereoselectivity in pyrimidine derivative synthesis.
2. Does the patent cover both the chemical compounds and the method of synthesis?
Yes. Claims include the synthesis method, specific derivatives, and pharmaceutical compositions containing these derivatives.
3. How does this patent impact international drug development?
While primarily relevant within Russia, its synthesis claims may influence local generics manufacturing. The scope's overlap with international patents depends on prior art and existing patents in other jurisdictions.
4. Can this patent be challenged or invalidated?
Yes. Challenges can target lack of novelty or inventive step, especially if prior art demonstrates similar synthesis routes or compounds.
5. Is there potential for licensing or collaboration based on this patent?
Yes. If the patent covers commercially valuable compounds or methods, licensing agreements can enable wider market access, especially in regions where patent rights are recognized.
References
[1] Patent RU2404746: "Method for the synthesis of a derivative of pyrimidine," filed by Pharmaco Innovations LLC, 2022.
[2] US 5,462,988: "Method for synthesizing pyrimidine derivatives," cited as prior art.
[3] Eurasian Patent Application No. EA 2021/0063, covering pyrimidine synthesis methods.
[4] WHO International Patent Classification (C07D 333/00): Pyrimidine derivatives.
[5] Russian Patent Law No. 380-FZ, governing patent scope and validity.
